New fixation method streamlines blood sample handling for translational research SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of Evercode™ Whole Blood Fixation, a new kit that enables immediate fixation of whole blood directly at the point of collection. The technology eliminates the need […]

SAN DIEGO — AlidaBio today announced the launch of the EpiPlex™ Duo-Mod™ Service, a turnkey offering that maps and quantifies m6A and inosine RNA modifications alongside RNA expression in a single integrated report. The service is designed for researchers who need sensitive RNA modification detection, relative quantitation, and high-quality RNA-seq data from precious clinical samples including fresh […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Sanjeev Mehra to its Board of Directors, effective immediately. Mr. Mehra is Co-Founder and serves as Managing Partner of Periphas Capital LP, a private […]

We’re proud to highlight that Tyrolpath, the largest private pathology lab in western Austria, is the first lab in Austria to adopt MSK-IMPACT®-Flex powered with SOPHiA DDM™, marking a major milestone for precision oncology in the country. With approximately 45,000 new cancer diagnoses reported each year, there is a strong need for comprehensive genomic profiling (CGP) to identify […]

Stellar Scientific expands its catalog with Accuris SmartDye Trademark Terminator v3.1, offering labs a reliable and cost-effective option for Sanger sequencing. The addition supports consistent results and enhances access to high-quality sequencing reagents. Affordable Alternative to BigDye Trademark Offers Significant Savings for Labs Using Traditional Sequencing Methods Stellar Scientific, a specialized supplier of molecular biology […]

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region WALTHAM, Mass. —  Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is […]

Natick, Mass. – Pillar Biosciences, the leader in Decision Medicine™, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized its pricing determination for oncoReveal CDx. Following its preliminary decision in August 2025, CMS confirmed a crosswalk-based payment rate of $1,352.09, effective for claims with dates of service on or after January 1, […]

Dr. Sebastian Heiner is set to take over the position of CEO of Greiner Bio-One International GmbH on December 1, 2025. Dr. Heiner was most recently a member of the Executive Board at FUCHS SE, and brings with him a wealth of international management experience and expertise in the disciplines of technology development, operational excellence […]

AMSTERDAM  Optics11 Life, the commercial-stage company pioneering mechanobiology instrumentation, today announced the appointment of Jacquelien ten Dam as Chief Executive Officer. Jacquelien has a unique combination of commercial expertise and life sciences knowledge to lead the company’s next growth phase. “Jacquelien is exactly what we need at this stage: proven commercial leadership combined with a […]

Vienna, Austria – Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation project producing comprehensive functional genomics datasets from primary human hepatocytes with Ochre Bio. The project included over 120,000 samples assessed with Lexogen’s proprietary extraction-free, high-resolution gene expression profiling platform and NGS Services. […]